Inventor

CHARI RAVI

US14 patents

⚠️ This page may combine multiple inventors who share the name “CHARI RAVI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ABBVIE INC

4 patents

US9045551B2Jun 2, 2015

Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof

ABBVIE INC12 citations82

US9670276B2Jun 6, 2017

IL-1 binding proteins

ABBVIE INC15 citations79

US9944720B2Apr 17, 2018

Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof

ABBVIE INC4 citations71

US9840554B2Dec 12, 2017

Antibodies against platelet-derived growth factor (PDGF)

ABBVIE INC2 citations68

REGENERON PHARMA

4 patents

US11525629B2Dec 13, 2022

Target residual moisture content for lyophilized drug product

REGENERON PHARMA4 citations81

US12066246B2Aug 20, 2024

Target residual moisture content for lyophilized drug product

REGENERON PHARMA2 citations70

US11713922B2Aug 1, 2023

Target residual moisture content for lyophilized drug product

REGENERON PHARMA3 citations70

US12449198B2Oct 21, 2025

Target residual moisture content for lyophilized drug product

REGENERON PHARMA0 citations59

ZOETIS BELGIUM S A

2 patents

US10125192B2Nov 13, 2018

Caninized anti-NGF antibodies and their use

ZOETIS BELGIUM S A5 citations79

US10093725B2Oct 9, 2018

Anti-NGF antibodies and their use

ZOETIS BELGIUM S A5 citations79

LI WEI

1 patent

US8426402B2Apr 23, 2013

Benzodiazepine derivatives

LI WEI69 citations96

LACY SUSAN E

1 patent

US9505829B2Nov 29, 2016

Anti-NGF antibodies and their use

LACY SUSAN E14 citations88

CHARI RAVI

1 patent

US8563509B2Oct 22, 2013

Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates

CHARI RAVI18 citations83

GU JIJIE

1 patent

US9163093B2Oct 20, 2015

Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof

GU JIJIE5 citations80